System Laboratories UK Ltd 30/09/2021 iXBRL

System Laboratories UK Ltd 30/09/2021 iXBRL

SYSTEM LABORATORIES UK LTD - Company Information

Print Friendly Version

1 30/09/2021 2021-09-30 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2020-09-10 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12870872 2020-09-10 2021-09-30 12870872 2021-09-30 12870872 core:PlantMachinery 2020-09-10 2021-09-30 12870872 core:FurnitureFittingsToolsEquipment 2020-09-10 2021-09-30 12870872 bus:RegisteredOffice 2020-09-10 2021-09-30 12870872 bus:Director1 2020-09-10 2021-09-30 12870872 bus:Director2 2020-09-10 2021-09-30 12870872 bus:Director3 2020-09-10 2021-09-30 12870872 bus:Director4 2020-09-10 2021-09-30 12870872 bus:Director5 2020-09-10 2021-09-30 12870872 bus:Director6 2020-09-10 2021-09-30 12870872 core:LandBuildings core:ShortLeaseholdAssets 2021-09-30 12870872 core:PlantMachinery 2021-09-30 12870872 core:FurnitureFittingsToolsEquipment 2021-09-30 12870872 core:ShareCapital 2020-09-10 2021-09-30 12870872 core:RetainedEarningsAccumulatedLosses 2020-09-10 2021-09-30 12870872 core:WithinOneYear 2021-09-30 12870872 core:ShareCapital 2021-09-30 12870872 core:RetainedEarningsAccumulatedLosses 2021-09-30 12870872 core:LandBuildings core:ShortLeaseholdAssets 2020-09-10 2021-09-30 12870872 bus:SmallEntities 2020-09-10 2021-09-30 12870872 bus:AuditExempt-NoAccountantsReport 2020-09-10 2021-09-30 12870872 bus:FullAccounts 2020-09-10 2021-09-30 12870872 bus:SmallCompaniesRegimeForAccounts 2020-09-10 2021-09-30 12870872 bus:PrivateLimitedCompanyLtd 2020-09-10 2021-09-30
Company registration number: 12870872
System Laboratories UK Ltd
Unaudited filleted financial statements
30 September 2021
System Laboratories UK Ltd
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
System Laboratories UK Ltd
Directors and other information
Directors Mr A Gitarts
Mr A James (Appointed 14 February 2022)
Mr S Remo (Resigned 4 January 2022)
Mr S Bachar (Resigned 14 February 2022)
Mr P Timmins (Resigned 4 January 2022)
Mr S Bioko (Resigned 14 February 2022)
Company number 12870872
Registered office 24 Bruton Place
London
W1J 6NE
System Laboratories UK Ltd
Statement of financial position
30 September 2021
30/09/21
Note £ £
Fixed assets
Tangible assets 5 44,489
_______
44,489
Current assets
Debtors 6 49,175
Cash at bank and in hand 36,224
_______
85,399
Creditors: amounts falling due
within one year 7 ( 234,748)
_______
Net current liabilities ( 149,349)
_______
Total assets less current liabilities ( 104,860)
_______
Net liabilities ( 104,860)
_______
Capital and reserves
Called up share capital 100
Profit and loss account ( 104,960)
_______
Shareholders deficit ( 104,860)
_______
For the period ending 30 September 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 26 April 2022 , and are signed on behalf of the board by:
Mr A Gitarts
Director
Company registration number: 12870872
System Laboratories UK Ltd
Statement of changes in equity
Period ended 30 September 2021
Called up share capital Profit and loss account Total
£ £ £
At 10 September 2020 - - -
Loss for the period ( 104,960) ( 104,960)
_______ _______ _______
Total comprehensive income for the period - ( 104,960) ( 104,960)
Issue of shares 100 100
_______ _______ _______
Total investments by and distributions to owners 100 - 100
_______ _______ _______
At 30 September 2021 100 ( 104,960) ( 104,860)
_______ _______ _______
System Laboratories UK Ltd
Notes to the financial statements
Period ended 30 September 2021
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 24 Bruton Place, London, W1J 6NE.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
No provision for deferred taxation has been provided for in the financial statements, due to the amount not being material.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Short leasehold property - Straight line over the life of the lease
Plant and machinery - 25 % straight line
Fittings fixtures and equipment - 25 % straight line
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1
5. Tangible assets
Short leasehold property Plant and machinery Fixtures, fittings and equipment Total
£ £ £ £
Cost
At 10 September 2020 - - - -
Additions 33,573 20,486 3,022 57,081
_______ _______ _______ _______
At 30 September 2021 33,573 20,486 3,022 57,081
_______ _______ _______ _______
Depreciation
At 10 September 2020 - - - -
Charge for the year 6,714 5,122 756 12,592
_______ _______ _______ _______
At 30 September 2021 6,714 5,122 756 12,592
_______ _______ _______ _______
Carrying amount
At 30 September 2021 26,859 15,364 2,266 44,489
_______ _______ _______ _______
6. Debtors
30/09/21
£
Other debtors 49,175
_______
7. Creditors: amounts falling due within one year
30/09/21
£
Trade creditors 30,374
Social security and other taxes 1,124
Other creditors 203,250
_______
234,748
_______